scispace - formally typeset
C

Chang-Hee Suh

Researcher at Ajou University

Publications -  189
Citations -  3755

Chang-Hee Suh is an academic researcher from Ajou University. The author has contributed to research in topics: Medicine & Rheumatoid arthritis. The author has an hindex of 28, co-authored 169 publications receiving 2940 citations.

Papers
More filters
Journal ArticleDOI

Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus

TL;DR: The data suggest that IL-6 and IL-10 may be a useful biomarker for disease activity in SLE, and no significant differences in the levels of cytokines were observed between SLE patients with nephitis and those without nephritis.
Journal ArticleDOI

Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells

TL;DR: Bifidobacterium bifidum is defined as a potent inducer of Foxp3+ Treg cells with diverse T cell receptor specificity to dietary antigens, commensal bacteria, and B. bifodum itself, and CSGG is identified as a functional component of Treg-inducing bacteria, highlighting the immunomodulatory potential of CSGG and CS GG-producing microbes.
Journal ArticleDOI

Significant association of FcɛRIα promoter polymorphisms with aspirin-intolerant chronic urticaria

TL;DR: The results suggest that the −344C>T polymorphism of the FcɛRIα promoter may be associated with increased expression of Fc√RIα on mast cells and enhanced release of histamine.
Journal ArticleDOI

Korean versions of the Perceived Stress Scale (PSS‐14, 10 and 4): psychometric evaluation in patients with chronic disease

TL;DR: The KPSS-10 exhibited a first-order, two-factor construct, and excellent reliability and validity were established for Korean patients with chronic disease, while the psychometric properties of the shortest version of the PSS were only marginally acceptable.
Journal ArticleDOI

Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males

TL;DR: This data indicates that antagonists of CysLTR1‐selective antagonists have anti‐bronchoconstrictive and anti‐inflammatory effects in asthma, particularly aspirin‐intolerant asthma (AIA).